Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...

HistoSonics, a medical device company backed by Johnson & Johnson’s venture capital arm, is exploring the possibility of a U.S. initial ...

Johnson & Johnson, founded in 1886, makes and sells medical devices, pharmaceuticals, and consumer health products. Headquartered in New Brunswick, N.J., the company operates over 250 subsidiary ...

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

The purchase is one of several transactions in recent years to boost its pharmaceuticals and medical devices units ... wield substantial influence. Johnson & Johnson, a multinational corporation known ...

In 2021, Johnson & Johnson unveiled a plan to spin off its consumer products division to focus on pharmaceuticals and medical technology. The company completed the Kenvue spinoff to shareholders ...

Sales across other products were only down 1%. In 2020 and 2021 (albeit to a lesser degree in 2021), Johnson and Johnson benefitted from some unique, one-time tax benefits. These benefits did not ...

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...

Johnson & Johnson (JNJ ... world's biggest maker of health care products have depreciated by 7.4% over the course of the past month, underperforming the Medical sector's loss of 7.03% and the ...

The global bone growth products market report includes exclusive data on 30 vendors. The market is highly competitive, with global players like Medtronic, Johnson & Johnson, Stryker, and Zimmer ...

In the latest trading session, Johnson & Johnson (JNJ ... world's biggest maker of health care products has risen by 0.15% in the past month, leading the Medical sector's loss of 2.46% and ...